MYC and colorectal carcinoma: We have found that FoxO3a participate in cetuximab resistant through directly binding to c-Myc promoter and activate its transcription, thus promote c-Myc down stream ACO2, LARS2 and MRPL12 genes in RAS WT CRC cells.